- Home
- FTF vs HRMY Comparison
FTF vs HRMY Comparison
Compare FTF & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTF
- HRMY
- Stock Information
- Founded
- FTF 2003
- HRMY 2017
- Country
- FTF United States
- HRMY United States
- Employees
- FTF N/A
- HRMY N/A
- Industry
- FTF Finance/Investors Services
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- FTF Finance
- HRMY Health Care
- Exchange
- FTF Nasdaq
- HRMY Nasdaq
- Market Cap
- FTF 1.9B
- HRMY 2.0B
- IPO Year
- FTF N/A
- HRMY 2020
- Fundamental
- Price
- FTF $6.57
- HRMY $36.42
- Analyst Decision
- FTF
- HRMY Strong Buy
- Analyst Count
- FTF 0
- HRMY 8
- Target Price
- FTF N/A
- HRMY $55.00
- AVG Volume (30 Days)
- FTF 153.9K
- HRMY 556.0K
- Earning Date
- FTF 01-01-0001
- HRMY 02-20-2025
- Dividend Yield
- FTF 11.45%
- HRMY N/A
- EPS Growth
- FTF N/A
- HRMY N/A
- EPS
- FTF N/A
- HRMY 2.11
- Revenue
- FTF N/A
- HRMY $681,879,000.00
- Revenue This Year
- FTF N/A
- HRMY $24.79
- Revenue Next Year
- FTF N/A
- HRMY $19.00
- P/E Ratio
- FTF N/A
- HRMY $17.31
- Revenue Growth
- FTF N/A
- HRMY 25.83
- 52 Week Low
- FTF $5.76
- HRMY $28.14
- 52 Week High
- FTF $6.56
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- FTF 49.91
- HRMY 61.49
- Support Level
- FTF $6.53
- HRMY $33.16
- Resistance Level
- FTF $6.66
- HRMY $37.16
- Average True Range (ATR)
- FTF 0.08
- HRMY 1.26
- MACD
- FTF 0.01
- HRMY 0.22
- Stochastic Oscillator
- FTF 59.26
- HRMY 81.50
About FTF Franklin Limited Duration Income Trust of Beneficial Interest
Franklin Limited Duration Income Trust is a closed-end investment company based in the United States. It conducts its investment to provide high, current income, with a secondary objective of capital appreciation. To align with its investment objective is to invest in a diversified mix of fixed-income securities. Its portfolio is dominated by considerable investments in high-yield corporate bonds while touching upon other avenues such as senior secured floating rate corporate loans, mortgage-backed securities, commercial mortgage-backed securities, asset-backed securities, common stocks, and other short-term investments.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.